The development of intestinal microflora and its effects on gastrointestinal health have been the focus of research in recent years. As a biotechnology company keeping pace with times, Creative Biolabs has invested numerous energy and efforts in the development of probiotics-based drug discovery. Learn more: bacteria christensenella

Health and safety consulting companies specialize in providing expert guidance and support to organizations across various industries to ensure compliance with health and safety regulations and to foster a safe working environment. These companies offer a range of services, including risk assessments, safety audits, development of safety policies and procedures, employee training programs, and ongoing support for implementing and maintaining health and safety standards. By partnering with health and safety consulting firms, businesses can mitigate risks, reduce accidents and injuries, improve workplace morale, and ultimately enhance productivity and profitability. These consulting companies typically employ professionals with expertise in occupational health and safety, regulatory compliance, industrial hygiene, and risk management to deliver tailored solutions to their clients' specific needs.

Coagulation factor II is proteolytically cleaved to form thrombin in the first step of the coagulation cascade which ultimately results in the stemming of blood loss. F2 also plays a role in maintaining vascular integrity during development and postnatal life. Learn more: f2 antibody

Empowered by state-of-the-art technologies and advanced platforms in the field of antibody discovery and immunotherapy, Creative Biolabs offers world-leading chimeric antigen receptor macrophage (CAR-MA) services for solid tumor treatment with academic purposes. Learn more: chimeric antigen receptor macrophages

Composed of ribosomal RNA molecules and proteins, ribosomes are important tools for protein synthesis in cells. ribosome complex profiling provides information on all ribosomes active in the cell at a specific time point and helps determine which proteins are actively translated in the cell. In life activities, mRNA translation is a key link that represents the flow of genetic information as well as defines the proteome.

Cardiovascular disease (CVD) is a general term for conditions affecting the heart or blood vessels. It's usually associated with a build-up of fatty deposits inside the arteries, known as atherosclerosis, and an increased risk of blood clots. It can also be associated with damage to arteries in organs such as the brain, heart, kidneys, and eyes. The risk factors for CVD include high blood pressure, smoking, diabetes mellitus, lack of exercise, obesity, among others. It is one of the main causes of death and disability but it can often largely be prevented with a healthy lifestyle. Learn more: cardiovascular diagnostic development

First demonstrated by Shinya Yamanaka's lab in 2006, the induced pluripotent stem cells (iPSCs) can be generated from different adult somatic cell types by the introduction of four transcription factors (OCT4, SOX2, KLF4, and MYC). With the pluripotency similar to embryonic stem cells (ESCs), iPSCs have shown great potential in drug discovery, disease modeling, and regenerative medicine research. Read Full Article: qPCR Analysis for Pluripotency Markers for iPSC

With the approval of two CAR-T cell therapies in 2017, the CAR-T cell treatment has been a promising tool for the treatment of advanced hematologic malignancies. However, although a lot of CAR-T cell therapies are under preclinical evaluation, this approach has not been proved to be as successful in solid tumors. One of the limitations in solid tumors lies in the poor penetration of T cells into tumors. To address this need, talented scientists from Creative Biolabs turn to genetically engineered CAR-MA, also termed MOTO-CAR, aiming to improve the ability of CAR cells to attack solid tumors. Learn more: CAR-macrophage

At Creative Biolabs, we are well-aware of the challenges of biopharmaceuticals development and the opportunities for non-IgG therapeutic antibodies development. Our rich experience and expertise in pharmacokinetics/pharmacodynamics (PK/PD) evaluation and customized solutions will help you get the useful information you need about your therapeutic antibody. With the advent of novel technologies, considerable advances have been made at Creative Biolabs in terms of PK/PD evaluation. Learn more: IgE antibodies PK/PD Evaluation

The human immune system is a complex network of cells, tissues, and organs that defend the body from harmful foreign invaders. A unique type of immune cells, called macrophages, plays a pivotal role in this defense mechanism through their flexibility to adapt to different stimuli and roles. More interestingly, macrophages also play a paradoxical role. Although they can mount defensive responses against tumor cells, they can potentially aid tumor growth and progression when they are hijacked, becoming tumor-associated macrophages (TAMs).

TAMs have gained significant interest in recent years due to their dual nature and their potential as targets for cancer therapies. To study these elusive cells, advanced techniques like tumor-associated macrophage isolation are imperative. This procedure involves separating TAMs from tumor tissue, enabling scientists to analyze these cells and their behavior closely. Through isolation, researchers can explore the characteristic features of TAMs, identify potential therapeutic targets, and determine how these cells contribute to tumorigenesis.

Once isolated, a closer look at TAMs reveals a more complex scenario. Macrophages aren't uniform; they can polarize or switch between different phenotypes in response to environmental cues. This polarization process results in two common types of macrophages: M1 and M2 macrophages.

The M1 macrophages, also known as 'killer' or 'pro-inflammatory' macrophages, are generally responsible for initiating the immune response against pathogens and tumor cells, producing pro-inflammatory cytokines, and promoting tissue damage. On the other hand, M2 macrophages, the 'repair' or 'anti-inflammatory' macrophages, suppress the immune response, aid in wound healing, and promote tissue remodeling.

In the context of cancer, TAMs often exhibit an M2-like phenotype. This phenotype transformation is a concerning phenomenon because while M1 macrophages can mediate anti-tumor effects, M2 macrophages can promote tumor growth and dissemination. However, macrophage polarization is not a one-way street. Intriguingly, M1 macrophages can also transform into M2 macrophages and vice versa, depending on the tumoral microenvironment dynamics.

Understanding the behavior of macrophage cells in the cancer context presents exciting possibilities for cancer treatment. For instance, therapeutic strategies could be designed to shift TAMs towards the M1 phenotype and elicit anti-tumor responses, or to interfere with the conversion of M1 to M2 macrophages.

Moreover, several immunotherapeutic strategies aimed at modulating macrophage functions are under clinical investigation. For example, some therapies aim to deplete TAMs, block their recruitment, or reprogram them to elicit anti-tumor responses.

In conclusion, the biology of macrophages is complex, and their role in cancer is multifaceted. The ability to isolate TAMs and understand their polarization dynamics can provide crucial knowledge for developing new therapeutic strategies against cancer. With a deep understanding of immune systems and command of technologies to manipulate them, diseases like cancer can be combated more precisely and effectively.